Krisztina Emodi, NP

Krisztina Emodi practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Krisztina Emodi's NPI, 1831573633, was assigned on July 13, 2015. Krisztina Emodi holds California license NP23637.

Krisztina Emodi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Krisztina Emodi's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Krisztina Emodi is also affiliated with Renown Regional Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Krisztina Emodi to 3 more hospitals, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Krisztina Emodi practices, 7 sites in all. Vendor and product names are available with a free account.

Family is Krisztina Emodi's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Krisztina Emodi is licensed in California.

CMS data shows 656 Medicare services from Krisztina Emodi across 6 procedure codes in 2024, for 288 Medicare patients. Medicare paid $28,846 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 288 Medicare patients who saw Krisztina Emodi in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have cancer, and 72% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Krisztina Emodi's median patient age at 74, with 27% women.

In 2024, Krisztina Emodi wrote 547 Medicare Part D claims for 216 patients. 96% of them were for generic drugs. CMS names the drug for 406 of them, across 11 drugs with 11 or more claims each, at $20,373 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Krisztina Emodi for performance year 2024, reported as part of a group. Krisztina Emodi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Krisztina Emodi as offering telehealth.

Dmand AI links 5 papers to Krisztina Emodi. The most frequent topics are Ostomy, Postoperative Period and Surgical Stomas. Krisztina Emodi has published most often in Int J Tuberc Lung Dis. Krisztina Emodi's most frequent co-authors are Sima Prabodh Porten, MD and Elizabeth Rachael Raskin, MD.

CMS Open Payments shows 16 general payments to Krisztina Emodi from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $629.

Dmand AI lists 1 award for Krisztina Emodi, most recently Excellence in Advanced Practice Award in 2022.